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Abstract: Imidazoles and their derivatives are compounds with chemotherapeutic   applications. 
In this study, we investigated the chemical functionalization of carboxylated multiwalled 
carbon nanotubes (MWNT–COOH) by 1,2-phenylendiamine. Multiwalled nanotube 
(MWNT)–benzimidazole was obtained by an MWNT–amide reaction with POCl3 after 72 hours, 
which was confirmed by Fourier transform infrared, scanning electron microscopy, thermal 
gravimetric analysis, and elemental analysis. These functionalizations were chosen due to -NH2 
and NHCO active sites in MWNT–amide for future application. Toxicity assays with fibroblast 
cells and MTT test for measurement of viable cell numbers were also performed. Cellular results 
did not show any toxicity change in modified samples from that of the reference samples.
Keywords: functionalization, 1,2-phenylendiamine, carboxylated multiwall nanotubes, 
toxicity
Introduction
Incorporation of imidazole and benzimidazole nuclei is an important synthetic strat-
egy in drug discovery.1 Observations suggest that substituted benzimidazoles and 
related heterocycles, which are the structural isosteres of nucleotides owing to fused 
heterocyclic nuclei in their structures, allow them to interact easily with biopolymers, 
and possess potential activity with lower toxicity in the chemotherapeutic approach 
in man.2,3 The high therapeutic properties of related drugs have encouraged medicinal 
chemists to synthesize a large number of novel chemotherapeutic agents. The anti-
tumoral activity of benzimidazole and its components have been reported in several 
studies. Furthermore, there are clinical anticancer drugs, known as Hoechst-33258 and 
Hoechst-33342 dyes, which include a benzimidazole structure.4,5 Carbon nanotubes 
have been attracting increasing attention from chemists and scientists owing to their 
electronic, mechanical, optical, and chemical characteristics.6–8 Biomedical applications 
for MWNTs are being investigated actively because of their useful combination of size 
and physicochemical properties.9–13 In patients with cancer, MWNTs have potential 
roles in delivering pharmacologic agents, as diagnostic imaging agents, DNA, silent 
interfering RNA, oligonucleotides, and proteins to detect or treat cancerous cells.14–16 
The application of functionalized carbon nanotubes as new nanovectors for drug 
delivery was apparent immediately after the first demonstration of the capacity of this 
material to penetrate into cells. Carbon nanotubes can be used to deliver their cargoes 
to cells and organs. Two papers17,18 detail the potential use of MWNTs to treat several 
types of cancer, with minimal or no toxic effects to normal cells.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Compounds such as imidazole are also well known 
antitumor agents.19–22 Carbon nanotubes also show good 
antitumoral effects. These materials can diffuse into cells 
and destroy DNA. Functionalization of carbon nanotubes 
with imidazole derivatives can leave mutual effects on 
  cancerous cells. In recent years, chemical functionalization 
of carbon nanotubes has become more interesting because 
it allows modification of the nanotube surface for subsequent 
alignment. These surface modifications play an important 
role for application of nanotubes in composite sensors and 
many other fields. The chemical modifications of carbon 
nanotubes have been well summarized in several published 
review articles.23–29 Amines are among the reagents that have 
drawn the greatest attention. Haddon et al pioneered the 
approach of functionalizing the carboxylic groups of carbon 
nanotubes through amidation with amines bearing long alkyl 
chains.30–33 On the other hand, acid-chloride-functionalized 
carbon nanotubes are used for attaching glucosamine34 and 
didecylamine.35 Amidation of carbon nanotubes has also 
been carried out with aromatic amines.36–38 In this paper, we 
investigated the formation of a pentaheterocyclic, MWNT–
benzimidazole, on MWNT nanotubes, in addition to devel-
oping the amidation of MWNT with bifunctional aromatic 
amines. Functionalized carbon nanotubes were characterized 
by Fourier transform infrared (FT-IR), scanning electron 
microscopy (SEM), thermal gravimetric analysis (TGA), 
elemental analysis, and toxicity assay.
Materials and methods
Preparation of MWNT–amide
MWNT–COOH 60 mg (20–30 nm; Netvino Co. Ltd) were 
sonicated in 90 mL of N,N-dimethyl formamide (DMF) for 
45 minutes to give a homogeneous suspension. Oxalyl chlo-
ride (2.5 mL) was added dropwise to the MWNT suspension 
at 0°C under nitrogen. The mixture was stirred at 0°C for 
two hours and followed at room temperature for the same 
duration. Finally, the temperature was increased to 70°C and 
the mixture was stirred overnight to remove excess oxalyl 
chloride. 1,2-phenylendiamine 100 mg dissolved in DMF 
was added to the MWNT suspension and the mixture stirred 
at 95°C for 72 hours. After cooling to room temperature, the 
mixture was filtered and washed thoroughly with DMF, ethyl 
alcohol, and tetrahydrofuran. Subsequently, the black solid 
was vacuum-dried at room temperature for five hours.
Preparation of MWNT–benzimidazole
MWNT–amide 30 mg was mixed with 10 mL POCl3 and then 
stirred at 80°C for 72 hours. After cooling to room   temperature, 
the reaction mixture was separated by   centrifugation and 
washed thoroughly with tetrahydrofuran.   Thereafter, the solid 
obtained was vacuum-dried for four hours.
Instrumental analysis
All reagents and solvents (oxalyl chloride, 1,2-phenylen-
diamine, phosphoryl trichloride, and DMF) were obtained 
from Merck Chemical Inc. (Darmstadt, Germany), and 
MWCNT–COOH (95% purity, 20–30 nm; Netvino Co. Ltd) 
were purchased and used as received. The FT-IR spectrum 
was recorded using KBr tablets on a Nexus 870 FT-IR spec-
trometer (Thermo Nicolet, Madison, WI). SEM was used to 
study the morphology of the WCNTs. SEM measurement 
was carried out on the XL30 electron microscope (Philips, 
Amsterdam, Netherlands). Elemental analyses of carbon, 
hydrogen, and nitrogen were performed using a Series ΙΙ 2400 
(Perkin Elmer, Waltham, MA). The samples were investigated 
by TGA (DuPont Instrument 951; DuPont, Wilmington, DE) 
in air (10°C/min).
cytotoxicity analysis
A fibroblast cell suspension (L929) from mouse tails was 
prepared according to ISO10993standards. The powders 
to control (TCPS) were well cleaned and sterilized by the 
autoclave method. Individual samples were placed in Petri 
dishes using a sterilized pincer; 3 cc of the cell suspension 
were removed by pipette and poured into the control and 
experimental samples. Thereafter, all of the samples were 
separately placed in a Memmert incubator at 37°C for 24 
and 48 hours. The samples in the polystyrene Petri dish 
were removed from the incubator after 24 and 48 hours and 
studied using a Eclipse TS-100 photonic microscope (100 ×; 
Nikon, Tokyo, Japan). Cell proliferation was determined by 
MTT assay for viable cell numbers. The MTT tetrazolium 
compound is reduced by living cells into a colored 
formazan product that is soluble in tissue culture medium. 
The quantity of formazan product is directly proportional 
to the number of viable cells in the culture. The assays 
were performed by adding 1 mL of MTT solution (Sigma, 
St. Louis, MO) and 9 mL fresh medium to each well after 
Table 1 Elemental analysis of the modified multiwalled carbon 
nanotubes (MWNT)
MWNT %C %H %N
1 96.4 0.04 0
2 89.7 1.31 2.09
3 85.2 0.96 1.47International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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aspirating the spent medium and incubating at 37°C for four 
hours with protection from light. Colorimetric measurement 
of formazan dye was performed at a wavelength of 570 nm 
using a Rayto microplate reader.
Results
Elemental analyses of the modified MWNT 1–3 are shown in 
Table 1. Apart from the carbon values, the atomic percentages of 
hydrogen 1.31% and nitrogen 2.09% of 2 (as compared with 1) 
indicated that 1 is functionalized with 1,2-  phenylendiamine. 
On the other hand, the   percentage decrease in   hydrogen from 
1.31% to 0.96% confirms the five-ring   formation. Based 
on these data, coupled with the   assumption that the atomic 
percentages of nitrogen and hydrogen originated from the 
aromatic amine without elimination, we confirmed the func-
tionalization of MWNT–COOH with 1,2-phenylendiamine. 
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Figure 1 Synthesis route of the modified carboxylated multiwalled carbon nanotubes.
3
2
9
4
1
0
4
5
1
0
4
5
1
7
1
0
3
4
3
8
%
 
t
r
a
n
s
m
i
t
t
a
n
c
e
3
4
3
8
6
1
7
1
1
0
3
1
1
5
0
1
2
3
8
1
4
0
2
1
5
2
3
1
5
7
4
1
7
0
0
2
8
4
7
2
9
1
2
3
4
1
2
2
9
4
1
1
6
5
4
1
6
1
0
1
4
5
9
1
4
1
0
1
3
3
6
1
1
7
3
1
1
0
7
1
5
4
5
1
7
3
0
2
8
4
5
2
9
1
1
Wavenumbers (cm−1)
3
2
1
3500 3000 2500 2000 1500 1000
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Figure 3 raman spectra of carboxylated multiwalled carbon nanotubes and benzimidazole multiwalled carbon nanotubes.
A B
Figure 4 scanning electron microscopy images of A carboxylated multiwalled carbon nanotubes and B benzimidazole multiwalled carbon nanotubes.
Figure 1 shows the synthesis route of the modified   
MWNT–COOH.
Figure 2 shows the FT-IR spectrum of the modified 
MWNTs. In spectrum 1, the band at around 1550 cm 
corresponds to the stretching mode of the C = C double 
bond that forms the framework of the carbon nanotube 
sidewall.24,25 The peak at 1730 and 1045 cm apparently 
corresponds to the stretching modes of the carboxylic acid 
groups.26 The two bands at 2800–2950 cm which are seen in 
all spectra are attributed to CH stretching of MWNT–COOH 
defects. In spectrum 2, the new strong peaks at 3200–3500 can 
be assigned to the N-H, NH2, and OH stretching modes. The International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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carbonyl peak in the spectrum 2 shift to 1654 cm (as compared 
with 1730 cm in spectrum 1) is a result of amide C ( = O)
NH linkage formation. The other peak at around 1610 cm 
can be assigned to the NH2 scissoring mode27 in 2 that over-
laps with the C = C mode. The peaks at around 1520–1590, 
1400–1480, 1200–1350, and 1100 cm correspond to C = C 
stretching nanotubes, aromatic ring modes, and C-N and C-O 
stretching modes, respectively. In spectra 3, the peaks of the 
amide group disappear and three peaks at around 1580, 620, 
and 1150 cm appear which can be assigned to imidazole ring 
stretching.28 The two peaks at 1710 and 1700 cm in spectra 2 
and 3, respectively, can be related to residual carboxylic acids 
on the nanotube. Thus, FT-IR spectra confirmed that MWNT–
COOH had been successfully modified by an   aromatic   
amine.
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Figure 5 Thermal gravimetric analysis curves of modified multiwalled carbon nanotubes in air (10°c/min).
Raman spectroscopy is a powerful tool used to provide 
structural information about MWNT–COOH before and 
after functionalization. As shown in Figure 3, the D and 
G bands of the MWNT at around 1348 and 1578 cm, 
attributed to defects, disorder-induced peaks, and tan-
gential-mode peaks,29–31 can be clearly observed for both 
MWNT–COOH and MWNT–benzimidazole. Addition-
ally, the intensity ratio (ID/IG) of the D and G bands for 
MWNT–benzimidazole is 1.15, which is greater than that 
for MWNT–COOH (0.64). The increase in intensity of the 
defect mode at 1348 cm was related to sp3 hybridization 
of carbon, and is used as an evidence of the disruption 
of the aromatic system of π electrons by the attached 
molecules.29
More direct evidence for the functionalization of MWNTs 
comes from the SEM images. Figure 4 indicates that the 
MWNT–COOH has a smooth surface. The changes in 
morphology are remarkable. A uniform tubular layer due 
to a covalently bonded aromatic amine on the surface of 
the MWNT (the rough part) is observable. It seems that the 
diameters of MWNT–benzimidazole are slightly increased 
in comparison with MWNT–COOH. This may be due to 
Table 2 MTT analysis of the samples
Sample λ(nm) Vialibility%
control 630 100
MWNT–Amide 317 50
MWNT–Benzimidazole 332 53
MWNT–cOOh 347 55International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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interaction between the grafted molecules of benzimidazole. 
The third structure is quite different from those of the   starting 
MWNT–COOH, in which the tube surface is relatively 
smooth and clean, as shown in Figure 4.
Figure 5 provides quantitative information on nanotube 
functionalization from the TGA results. In TGA graphs of 
MWNT–amide and MWNT–benzimidazole, two distinct 
decompositions are observable. The first one (below 360°C) 
can be assigned to the aromatic amine and benzimidazole of 
MWNT–amide and MWNT–benzimidazole, respectively, 
while the second one (above 360°C) is related to the nanotube 
as compared with the MWNT–COOH thermogram. If the 
mass loss of the MWNT–COOH at 360°C (0.88%) is used 
as the reference, the mass loss of functionalized MWNT by 
  1,2-phenylendiamine and benzimidazole of MWNT–amide 
and MWNT–benzimidazole at 360°C is about 19% and 
11.4%, respectively. These results indicate that there is one 
amide group for MWNT–amide per 47.9 and one benzimida-
zole group for MWNT–benzimidazole per 75.8 carbon atoms 
of MWNT, respectively. Figure 6 shows cellular images for 
this sample. Half of the cells in all three cases live. MTT 
analysis was also corroborated, as shown in Table 2.
Conclusion
In summary, we have introduced benzimidazole groups onto 
the surface of nanotubes via reaction of MWNT–amide with 
Figure 6 cell growth on the samples. control A) carboxylated multiwalled carbon nanotubes B) multiwalled benzimidazole carbon nanotubes C) and multiwalled amide 
carbon nanotubes D).International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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POCl3. Functionalization was demonstrated by their SEM 
images, as well as FT-IR, elemental analysis, and TGA. 
The results show successful functional groups and no change 
in toxicity in functional samples compared with the primary 
sample, with half of the cell growth on modified samples. In 
subsequent studies, antitumoral investigations of modified 
samples will be evaluated.
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